European Journal of Medicinal Chemistry p. 1066 - 1075 (2017)
Update date:2022-08-11
Topics:
Taguchi, Riho
Hatayama, Koki
Takahashi, Tomohito
Hayashi, Takafumi
Sato, Yuki
Sato, Daisuke
Ohta, Kiminori
Nakano, Hiroto
Seki, Chigusa
Endo, Yasuyuki
Tokuraku, Kiyotaka
Uwai, Koji
Amyloid-β aggregation inhibitors are expected to be therapeutic or prophylactic agents for Alzheimer's disease. Rosmarinic acid, which is one of the main aggregation inhibitors derived from Lamiaceae, was employed as a lead compound and its 25 derivatives were synthesized. In this study, the structure–activity relations of rosmarinic acid derivatives for the amyloid-β aggregation inhibitory effect (MSHTS assay), antioxidant properties, and xanthine oxidase inhibition were evaluated. Among the tested compounds, compounds 16d and 19 were found to the most potent amyloid aggregation inhibitors. The SAR revealed that the necessity of the presence of the phenolic hydroxyl on one side of the molecule as well as the lipophilicity of the entire molecule. The importance of these structural properties was also supported by docking simulations.
View MoreAngelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
Suzhou Howsine Biological Technology Co.,Ltd
website:http://www.howsine.com
Contact:86-512-67262751
Address:No 3,Weihua Road ,Suzhou Industrial Park ,Jiangsu ,China.
Qingdao XinYongAn Chemicals Co., Ltd
Contact:+86-532-81107967
Address:Chengyang dual-port industrial park by the sea,Qingdao
Contact:0833-5590788/5590338/5590055
Address:Victory in the town of Red Star Village,Mount Emei City,industrial concentration area storage processing logistics parkpark
Xian Changyue Biological Technology Co., Ltd.
website:https://www.xachangyue.com/
Contact:+86-029-62886900
Address:Keji Road NO.70
Doi:10.1063/1.2897325
(2008)Doi:10.1002/ejoc.201402902
(2014)Doi:10.1016/S0040-4039(00)89336-3
(1970)Doi:10.1007/s11243-014-9853-6
(2014)Doi:10.1016/j.tetlet.2018.10.040
(2018)Doi:10.1002/adsc.202100535
(2021)